Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose ascorbic acid and thiamine in severe sepsis ICU patients
IRCT20130812014333N78Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of ascorbic acid and thiamine in sepsis (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Organ dysfunction, Length of stay in ICU and 1 more. Started Dec 2017; status: completed.
02
Drugs
ascorbic acidthiamine
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20130812014333N78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N78.